Eversept Partners, LP
Top Portfolio Positions
110 positions ·
$1,817,420,308 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| UTHR |
UNITED THERAPEUTICS Corp
Healthcare
|
264,271 | $156,707,417 | 8.62% | |
| QQQ |
Invesco Qqq Trust, Series 1
|
238,700 | $137,772,866 | 7.58% | |
| ABVX |
Abivax S.A.
Healthcare
|
934,423 | $104,048,001 | 5.73% | |
| GSK |
GSK plc
Healthcare
|
1,785,175 | $98,523,808 | 5.42% | |
| VERA |
Vera Therapeutics, Inc.
Healthcare
|
2,173,286 | $87,431,295 | 4.81% | |
| NTRA |
Natera, Inc.
Healthcare
|
384,713 | $76,938,752 | 4.23% | |
| SPY |
Spdr S&P 500 ETF Trust
|
107,000 | $69,586,380 | 3.83% | |
| SNDX |
Syndax Pharmaceuticals Inc
Healthcare
|
2,885,622 | $67,408,129 | 3.71% | |
| CLDX |
Celldex Therapeutics, Inc.
Healthcare
|
1,788,016 | $56,715,867 | 3.12% | |
| PCVX |
Vaxcyte, Inc.
Healthcare
|
924,193 | $53,704,855 | 2.96% |
Portfolio Trend
25 quarters · across all stocks
Holdings in TVTX
Shares Held
Position Value (USD)
9 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $16,120,943 | 542,610 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $44,895,527 | 1,174,968 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $33,871,175 | 1,417,204 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $19,462,488 | 1,315,033 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $14,627,271 | 816,254 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $8,540,956 | 490,296 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $12,170,082 | 869,913 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $8,969,376 | 1,091,165 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $7,367,814 | 955,618 | Shares | Sole | 2024-05-15 | |
| No 13F history on record for this holder in this stock. | ||||||